Emma is a leader in Patient Engagement practices and policies since 1996 and is a Steering Committee Member for several pharma-academic research collaborations.
Please log into your account to view faculty contact details.
SVP Patient Insights and Solutions
An overview of patient engagement, benefits of investing in patient engagement programmes and why elevating patient engagement should be an essential business spend for patient safety, support and societal gain. Key Points Patient engagement is the next blockbuster drug. Patient engagement has long-proved to improve patient safety, reduce hospital admissions and substantially lower...
READ MOREA patient engagement authority reflects on the impact of pharma’s response to COVID-19 and outlines hope for a better perception of the sector as providers of health solutions beyond the pill. Since the first awareness of COVID-19 in the medical press and alert to the World Health Organization on December 31 2019, global health agencies and organisations have been in a cooperative...
READ MORESummary: A medical communications expert looks at how industry’s relationship with the patient has changed over 25 years and what is necessary for successful future liaison. It is twenty-five years since I first started working in medical communications and with patient organisations. In 1995 there was no such thing as ‘patient-centred behaviours.' There was clinical research,...
READ MOREWhy and how we need to assess patient centricity. Focusing on the issues and opportunities in quantifying patient engagement in pharma. It is an exciting time to be a member of the ‘patient economy’. For close to a decade pharma has worked relentlessly – sometimes seeming to run in circles – chasing the ‘perfect’ infrastructure to implement a company shift to a patient-centric focus....
READ MORE
